Skip to main content
. 2018 Mar 9;15(6):536–548. doi: 10.7150/ijms.23402

Table 1.

Clinic-pathological characteristics of Triple Negative Breast Cancer subtypes.

BLBC (n = 63)
n (%)
QNBC (n = 43)
n (%)
p-value*
Age (years) 58 (16) 57 (12) 0.78
Menstrual status 0.49
None 13 (45) 7 (32)
Physiological 11 (38) 12 (54)
Post-surgery 5 (17) 3 (14)
Site 0.14
Dx 33 (59) 17 (39)
Sx 22 (39) 24 (56)
Bilateral 1(2) 2 (5)
Histologic subtype 0.088
Ductal 42 (69) 28 (68)
Lobular 0 (0) 3 (7)
Other subtype 19 (31) 10 (24)
Size (cm) 0.78
≤ 2 cm 31 (51) 22 (54)
> 2 cm 30 (49) 19 (46)
pT 0.75
T1-T2 54 (87) 38 (91)
T3-T4 8 (13) 4 (9)
pN 0.407
N0-N1 47 (82) 31 (76)
N2-N3 10 (18) 10 (24)
Grade 0.279
1 4 (6) 2 (5)
2 13 (21) 4 (9)
3 46 (73) 36 (86)
Stage 0.404
I 13 (23) 13 (33)
II 30 (54) 16 (40)
III 13 (23) 11 (27)
Necrosis 0.188
Present 24 (41) 12 (29)
Absent 34 (59) 30 (71)
Tumor infiltrating lymphocyte 0.082
Present 21 (40) 24 (58)
Absent 31 (40) 17 (42)
Lympho-vascular invasion 0.255
Present 18 (35) 10 (24)
Absent 34 (65) 32 (76)
Margin's infiltration 0.561
Present 3 (8) 1 (4)
Absent 35 (92) 23 (96)
Ki67 0.105
≤ 35% 41 (67) 21 (51)
> 35% 20 (33) 20 (49)
Androgen receptors 0.854
Present 18 (29) 13 (30)
Absent 45 (71) 30 (70)
Surgery 0.507
Mastectomy 19 (35) 12 (28)
Lumpectomy 1 (2) 2 (5)
Quadrantectomy 31 (56) 28 (65)
Combined 4 (7) 1 (2)
EGFR < 0.0001
Positive 50 (79) 0 (0)
Negative 13 (21) 43 (100)
CK 5/6 < 0.0001
Positive 45 (71) 0 (0)
Negative 18 (29) 43 (100)

BLBC = Basal-like breast cancer

QNBC = Quintuple negative breast cancer

n = number

*The p-values are bold where they are less than or equal to the significance level of 0.05.